Skip to content

EVALUATION OF CURCUMIN FOR THE TREATMENT OF DEEP CAVITIES IN MILK TEETH.

A randomized, parallel group, active controlled trial to evaluate curcumin as a pulpotomy medicament in deciduous teeth

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/11/004160
Enrollment
100
Registered
2013-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Deciduous tooth with extensive caries but without evidence of radicular pathology when caries removal results in a carious or mechanical pulp exposure.

Interventions

Intervention1: 95 % curcumin: Following standard procedure, inflammed coronal pulp will be amputated, bleeding controlled with sterile cotton palette,95 % curcumin placed in direct contact with radicu

Sponsors

Maratha Mandals NGH institute of Dental Sciences Research Centre Belgaum
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Primary molars with vital carious pulp exposures that bleed upon entering the pulp chambers. 2. Teeth that could be restored with stainless steel crowns.

Exclusion criteria

Exclusion criteria: 1. Presence of spontaneous pain, pain on percussion, history of swelling or sinus tracts. 2. Radiographic signs of internal / pathological external resorption, widened PDL spaces and furcation radiolucency. 3. More than one third physiologic root resorption.

Design outcomes

Primary

MeasureTime frame
Widening of PDL space on the intra-oral peri-apical radiographTimepoint: 1,3,6 and 12 months

Secondary

MeasureTime frame
Gingival swelling (not due to poor oral hygiene)Timepoint: 1,3,6 and 12 months

Countries

India

Contacts

Public ContactDR PRAVEENKUMAR S MANDROLI

Bapuji Dental College and Hospital

attiguppeprabhakar@yahoo.com9449602506

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026